Nuclear medicine firm Digirad saw revenues for the company's second quarter (end-June 30) more than double thanks to contributions from its acquisition of DMS Health.
For the quarter, the company posted revenue of $32.1 million, up 106% from revenue of $15.5 million in the corresponding quarter of 2015. The company closed the DMS acquisition on January 1, 2016.
Digirad's net income for the most recent period was $998,000, down slightly from the $1.1 million reported in the second quarter of 2015.
